AflacLL1901 (CHOA-AML)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT
- Status
- UNKNOWN
- Phase
- PHASE4
Sorafenib PK in Patients With Advanced HCC and Child-Pugh B
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion
- Status
- UNKNOWN
- Phase
- PHASE2
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
- Status
- RECRUITING
- Phase
- PHASE2
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Status
- TERMINATED
- Phase
- PHASE1
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE3
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Irradiation Stent Placement Plus TACE for HCC and PVTT
- Status
- UNKNOWN
- Phase
- NA
Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE
- Status
- WITHDRAWN
- Phase
- PHASE2